Zheng Quan Ri Bao Zhi Sheng·2025-11-12 10:17Core Points - The company announced the transfer of 51% equity in its subsidiary Hainan Wanmitang Pharmaceutical Co., Ltd. to Guangdong He Yi Yun Kang Pharmaceutical Co., Ltd. for a price of RMB 3,373,543.10 [1] - The company has received the full payment for the equity transfer and has completed the necessary registration and documentation with the Hainan Provincial Market Supervision Administration [1] Summary by Category - Equity Transfer - The company approved the transfer of 51% equity in Hainan Wanmitang for RMB 3,373,543.10 [1] - The transfer has been fully paid by the acquiring party [1] - Regulatory Compliance - The company has completed the business registration changes and filed the updated articles of association [1] - A registration notice has been issued by the Hainan Provincial Market Supervision Administration [1]